Intramyocardial autologous CD34+ cell therapy for refractory angina: A meta-analysis of randomized controlled trials.

MLA

Velagapudi, Poonam, et al. “Intramyocardial Autologous CD34+ Cell Therapy for Refractory Angina: A Meta-Analysis of Randomized Controlled Trials.” Cardiovascular Revascularization Medicine : Including Molecular Interventions, vol. 20, no. 3, Mar. 2019, pp. 215–19. EBSCOhost, https://doi.org/10.1016/j.carrev.2018.05.018.

APA

Velagapudi, P., Turagam, M., Kolte, D., Khera, S., Hyder, O., Gordon, P., Aronow, H. D., Leopold, J., & Abbott, J. D. (2019). Intramyocardial autologous CD34+ cell therapy for refractory angina: A meta-analysis of randomized controlled trials. Cardiovascular Revascularization Medicine : Including Molecular Interventions, 20(3), 215–219. https://doi.org/10.1016/j.carrev.2018.05.018

Chicago

Velagapudi, Poonam, Mohit Turagam, Dhaval Kolte, Sahil Khera, Omar Hyder, Paul Gordon, Herbert D Aronow, Jane Leopold, and J Dawn Abbott. 2019. “Intramyocardial Autologous CD34+ Cell Therapy for Refractory Angina: A Meta-Analysis of Randomized Controlled Trials.” Cardiovascular Revascularization Medicine : Including Molecular Interventions 20 (3): 215–19. doi:10.1016/j.carrev.2018.05.018.